De Benedittis, G.; Latini, A.; Ciccacci, C.; Conigliaro, P.; Triggianese, P.; Fatica, M.; Novelli, L.; Chimenti, M.S.; Borgiani, P.
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis. J. Pers. Med. 2022, 12, 1094.
https://doi.org/10.3390/jpm12071094
AMA Style
De Benedittis G, Latini A, Ciccacci C, Conigliaro P, Triggianese P, Fatica M, Novelli L, Chimenti MS, Borgiani P.
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis. Journal of Personalized Medicine. 2022; 12(7):1094.
https://doi.org/10.3390/jpm12071094
Chicago/Turabian Style
De Benedittis, Giada, Andrea Latini, Cinzia Ciccacci, Paola Conigliaro, Paola Triggianese, Mauro Fatica, Lucia Novelli, Maria Sole Chimenti, and Paola Borgiani.
2022. "Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis" Journal of Personalized Medicine 12, no. 7: 1094.
https://doi.org/10.3390/jpm12071094
APA Style
De Benedittis, G., Latini, A., Ciccacci, C., Conigliaro, P., Triggianese, P., Fatica, M., Novelli, L., Chimenti, M. S., & Borgiani, P.
(2022). Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis. Journal of Personalized Medicine, 12(7), 1094.
https://doi.org/10.3390/jpm12071094
